AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19 Read more
Vaccine trials essential to evaluate effectiveness against new COVID-19 variants: GlobalData Read more
Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or refractory marginal zone lymphoma, follicular lymphoma Read more